The HPV FOCAL Trial is a RCT comparing human papilloma virus (HPV) with Liquid Based Cytology (LBC) screening for cervical cancer. Results are presented for the comparison of the Safety and Control ...

Knowledge of the prevalence of type-specific human papillomavirus (HPV) infections is necessary to predict the expected, and to monitor the actual, impact of HPV immunisation and to design effective ...

A new computerized screening test for cervical cancer detects more abnormalities than the traditional smear test, according to a study published online. A new computerised screening test for cervical ...

BD Life Sciences-Diagnostic Systems, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of BD SurePath Direct to Slide. It is a liquid ...

A new screening test for cervical cancer being introduced in some countries and considered in many others may in fact be worse than the test it is replacing, suggests controversial new research. The ...

Cervical cancer remains a significant global health challenge, particularly affecting women in low-resource settings. Effective screening methods are essential for early detection and prevention. This ...

Cervical cancer is the second most frequently occurring cancer in Indian women with one woman dying from it every eight minutes in India and the leading cause of death for women worldwide. Furthermore ...

Cervical Cancer, the third most common cancer in women in India, poses a significant global health challenge. Globally, over 540,00 people were diagnosed with Cervical Cancer in the year 2021, and ...

A new more efficient smear test now being introduced in Scotland will not be made available in the rest of the UK for at least a year. The system, known as liquid based cytology (LBC) has been hailed ...

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to utilize its BD ProbeTec(TM) ...

KOCHI: An awareness campaign — We Hope to Stop Cervical Cancer — was launched in the city on Wednesday to address the growing incidence of cervical cancer. January is cervical health awareness month.

A new computerised screening test for cervical cancer detects more abnormalities than the traditional smear test, according to a study published on bmj.com today. It could also lead to fewer women ...